{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-113.13",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.13 - Requirements for Dispensing Sites",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 § 113.13 - Requirements for Dispensing Sites\n\nState Regulations\n(a) Medical cannabis products at a dispensing site shall only be dispensed by\nauthorized employees, twenty-one (21) years of age or older, of the registered\norganization, under the inperson supervision of an individual with an active\n\nNew York State pharmacist license as defined in Article 137 of the Education\n\nLaw, who has completed at minimum a two (2) hour course pursuant to this\n\nPart. (b) Dispensing sites shall\nonly sell approved medical cannabis products, related products necessary for\nthe administration of medical cannabis, and items that promote health and\nwell-being subject to disapproval of the Office. (c) The registered organization shall offer\nand make available to patients at least one (1) medical cannabis product that\nhas a low THC and a high CBD content (e.g., a 1:20 ratio of THC to\nCBD); (d) The registered\norganization shall offer and make available at least one (1) medical cannabis\nproduct that has approximately equal amounts of THC and CBD; (e) Dispensing sites may display, in secure, locked cases, samples of each medical cannabis product offered for sale. Authorized employees may remove samples from the display case and provide it to\nthe medical cannabis certified patient or designated caregiver for inspection, provided the patient or caregiver may not consume or otherwise use or remove\nthe sample from the dispensing site. (f) No medical cannabis products shall be\nvaporized or consumed on the premises of a dispensing site. (g) Dispensing sites shall not dispense\nmedical cannabis products to anyone other than a certified patient, designated\ncaregiver, research license holder, or unless such registered organization, pursuant to Article 4 of the Cannabis Law, is authorized by the Office to sell\ncannabis for adult use for retail sale. (h) When dispensing medical cannabis, the\ndispensing site shall: (1)\nnot dispense any\nmedical cannabis to a certified patient, unless the certified patient presents\nthe dispensing site with: (i) a valid\ncertification from a practitioner, as defined in Article 1 of the Cannabis Law, and issued in accordance with, Article 3 of the Cannabis Law, which shall also\nserve as the certified patient's registry card; and\n(ii)\na valid government-issued photo\nidentification, which the dispensing site shall use to validate that such\npatient is eighteen (18) years of age or older and capable of consent as\ndocumented on the certification, provided that, such government-issue photo\nidentification, is issued by: (a) the New York\n\nState commissioner of motor vehicles; (b) the federal government of the United\n\nStates; (c) any United States\nterritory; (d) the District of\n\nColumbia; (e) a state, commonwealth, or local government within the United States; (f) a post-secondary educational institution\nregulated by the New York State Department of Education or another state; or\n(g) or a provincial government\nof the dominion of Canada; (2)\nuse the patient certification number as\nthe registry identification when a registry identification number is\nrequired; (3)\nnot dispense any\nmedical cannabis product to a designated caregiver, unless such caregiver\npresents a certification in accordance with section\n113.3\nof this Part and a form of\nphoto identification of such caregiver issued pursuant to this\nsection. (4)\nensure that medical\ncannabis product packaging shall not be opened by dispensing site\nstaff; (5)\nprovide a\npatient-specific log of medical cannabis products (brand, administration form, and dosage, and dates dispensed and any return of product) to the patient, the\npatient's designated caregiver, if applicable, or the patient's practitioner\nupon request; (i) The\nregistered organization shall be responsible for maintaining the\nconfidentiality of patients and the integrity of the security of the facility\nat all times. Access to medical cannabis storage areas and areas within the\ndispensing site where security equipment and recordings are stored shall be\nrestricted to: (1)\nregistered organization\nemployees; (2)\nemployees of the\n\nOffice or its authorized representatives; (3)\nemergency personnel responding to an\nemergency, and; (4)\nother persons\nauthorized by a manager of the registered organization for the sole purpose of\nmaintaining the operations of the facility. (j) The dispensing site shall maintain a\nvisitor log of all persons, other than registered organization employees or\nemergency personnel responding to an emergency, that access these secured\nareas, which shall include the name of the visitor, date, time and purpose of\nthe visit. The visitor log shall be available to the Office at all times during\noperating hours and upon request. (k) The dispensing site shall affix to the\nmedical cannabis product package a patient specific dispensing label, that is\neasily readable, and firmly affixed and includes the following information: (1)\nthe name and registry identification\nnumber of the certified patient and designated caregiver, if any; (2)\nthe certifying practitioner's\nname; (3)\nthe dispensing site name, address and phone number; (4)\nthe\ndosing and administration instructions; (5)\nthe quantity and date\ndispensed; (6)\nany recommendation\nor limitation by the practitioner as to the use of medical cannabis; and\n(7)\nthe expiration date of the\nproduct once opened pursuant to section\n113.12\n(n)(2)\nof\nthis Part, if not included on the cannabis product label pursuant to section\n113.12\nof this Part. (l) The dispensing site shall\ninclude with each product package dispensed to a patient, a package safety\ninsert. Information provided shall include but not be limited to: (1)\nthe medical cannabis product; (2)\ncontraindications; (3)\nspecific dosage directions and\ninstructions for administration based on the medical cannabis product form, including but not limited to onset of effect and duration of action; (4)\nwarning of adverse events and/or any\npotential dangers stemming from the use of medical cannabis; (5)\ninstructions for reporting adverse events\nas may be determined by the Office; (6)\na warning about driving, operation of\nmechanical equipment, or making important decisions while taking medical\ncannabis; (7)\ninformation on\ntolerance, dependence and withdrawal and substance abuse, how to recognize what\nmay be problematic usage of medical cannabis and obtain appropriate services or\ntreatment; (8)\nlanguage stating\nthat the medical cannabis product must be kept secure at all times, and out of\nsight and reach of children and pets; (9)\nlanguage stating that the certified\npatient may not distribute any medical cannabis product to anyone\nelse; (10)\nlanguage stating that\nunwanted, excess, or contaminated medical cannabis product must be disposed of\nin accordance with the requirements set forth in section\n113.21\nof this Part; and\n(11)\nlanguage stating that \"This product has\nnot been analyzed by the FDA. There is limited information on the side effects\nof using this product and there may be associated health risks.\"\n(12)\nlanguage stating, in bold: (i) \"This product might impair the ability to\ndrive.\"; (ii)\n\"Medical cannabis\nproducts must be kept in the original container in which they were dispensed\nand removed from the original container only when ready for use by the\ncertified patient.\"; and\n(iii)\n\"This product is for medicinal use only. This product should not be consumed\nduring pregnancy or while nursing except on the advice of the certifying\npractitioner, and in the case of a nursing parent, including the infant's\npediatrician.\"\n(m) The dispensing site shall store the\nmedical cannabis product in a manner to ensure that there is no contamination\nor deterioration of the medical cannabis product or its packaging. (n) If a medical cannabis product is returned\nto the dispensing site, the registered organization shall: (1)\ndispose of such product pursuant to\nsection\n113.25\nof this Part; (2)\nretain the following information for at\nleast five (5) years and make available to the Office upon request: (i) the name and registry identification\nnumber of the certified patient for whom the product was dispensed; (ii)\nthe date of the return; (iii)\nthe product being returned; (iv)\nthe quantity and/or weight being\nreturned; (v) the reason for the\nreturn; (vi)\nthe name of the\ndispensing site employee accepting the return; and\n(vii)\nany other information required by the\n\nOffice; (3)\nensure the\nreturned medical cannabis product is securely stored, separate from working\ninventory while awaiting disposal. (o) A registered organization shall provide a\nphysical or paper certificate analysis which includes, but is not limited to, the quality, safety and clinical strength of the medical cannabis product\nmanufcactied or dispensed by the registered organization directly to certified\npatients or their designated caregivers upon their request, in accordance with\nsection\n34\nof the Cannabis\n\nLaw. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.13\n\nAdopted\n\nNew\n\nYork State Register February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023\n\nAmended\n\nNew\n\nYork State Register March 27, 2024/Volume XLVI, Issue 13, eff. 3/27/2024\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. (a) Medical cannabis products at a dispensing\nsite\nshall only be dispensed by authorized employees, twenty-one (21) years of age or older, of the\nregistered organization, under the in-\nperson\nsupervision of an\nindividual\nwith an active New York\n\nState\npharmacist\nlicense\nas defined in Article 137 of the Education\n\nLaw, who has completed at minimum a two (2) hour course pursuant to this Part. (b) Dispensing sites shall only sell approved medical cannabis products, related products necessary for the administration of medical cannabis, and items that promote health and well-being subject to disapproval of the\n\nOffice. (c) Dispensing sites\nmay\ndisplay, in secure, locked cases, samples of each\nmedical cannabis product\noffered for sale. Authorized employees\nmay\nremove samples from the display case and provide it to the medical cannabis\ncertified patient\nor designated caregiver for inspection, provided the patient or caregiver\nmay\nnot consume or otherwise use or remove the sample from the dispensing\nsite. (d) No medical cannabis products shall be vaporized or consumed on the premises of a dispensing\nsite. (e) Dispensing sites shall not dispense medical cannabis products to anyone other than a\ncertified patient, designated caregiver, research\nlicense\nholder, or unless such\nregistered organization, pursuant to Article 4 of the Cannabis\n\nLaw, is authorized by the\n\nOffice\nto sell cannabis for adult use for retail sale. (f) When dispensing medical cannabis, the dispensing\nsite\nshall: (1)\nnot dispense any medical cannabis to a\ncertified patient, unless the\ncertified patient\npresents the dispensing\nsite\nwith: (i) a valid certification from a\npractitioner, as defined in Article 1 of the Cannabis\n\nLaw, and issued in accordance with, Article 3 of the Cannabis\n\nLaw, which shall also serve as the\ncertified patient\n's registry card; and\n(ii)\na valid government-issued photo identification, which the dispensing\nsite\nshall use to validate that such patient is eighteen (18) years of age or older and capable of consent as documented on the certification, provided that, such government-issue photo identification, is issued by: (a) the New York\n\nState\ncommissioner\nof motor vehicles; (b) the federal government of the United States; (c) any United States territory; (d) the District of Columbia; (e) a\nstate, commonwealth, or local government within the United States; (f) a post-secondary educational institution regulated by the New York\n\nState\n\nDepartment\nof Education or another\nstate; or\n(g) or a provincial government of the dominion of Canada; (2)\nuse the patient certification number as the registry identification when a registry identification number is required; (3)\nnot dispense any\nmedical cannabis product\nto a designated caregiver, unless such caregiver presents a certification in accordance with section\n113.3\nof this Part and a\nform\nof photo identification of such caregiver issued pursuant to this section. (4)\nnot dispense an amount greater than a sixty (60) day supply to a\ncertified patient, and not until the patient has exhausted all but a seven (7) day supply provided pursuant to any previously dispensed medical cannabis by any\nregistered organization; (5)\nensure that\nmedical cannabis product\npackaging shall not be opened by dispensing\nsite\nstaff; (6)\nprovide a patient-specific log of medical cannabis products (brand, administration\nform, and dosage, and dates dispensed and any return of product) to the patient, the patient's designated caregiver, if applicable, or the patient's\npractitioner\nupon request; (7)\nensure the prescription monitoring\nprogram\nregistry is consulted pursuant to 3343-a Public Health\n\nLaw\nand section 34 Article 3 of the Cannabis\n\nLaw\nprior to any sales transactions and dispensing of any medical cannabis products by the facility. (g) The\nregistered organization\nshall be responsible for maintaining the confidentiality of patients and the integrity of the security of the facility at all times. Access to medical cannabis storage areas and areas within the dispensing\nsite\nwhere security equipment and recordings are stored shall be restricted to: (1)\nregistered organization\nemployees; (2)\nemployees of the\n\nOffice\nor its authorized representatives; (3)\nemergency personnel responding to an emergency, and; (4)\nother persons authorized by a manager of the\nregistered organization\nfor the sole purpose of maintaining the operations of the facility. (h) The dispensing\nsite\nshall maintain a visitor log of all persons, other than\nregistered organization\nemployees or emergency personnel responding to an emergency, that access these secured areas, which shall include the name of the visitor, date, time and purpose of the visit. The visitor log shall be available to the\n\nOffice\nat all times during operating hours and upon request. (i) The dispensing\nsite\nshall affix to the\nmedical cannabis product\npackage a patient specific dispensing label, that is easily readable, and firmly affixed and includes the following information: (1)\nthe name and registry identification number of the\ncertified patient\nand designated caregiver, if any; (2)\nthe certifying\npractitioner\n's name; (3)\nthe dispensing\nsite\nname, address and phone number; (4)\nthe dosing and administration instructions; (5)\nthe quantity and date dispensed; (6)\nany recommendation or limitation by the\npractitioner\nas to the use of medical cannabis; and\n(7)\nthe\nexpiration date\nof the product once opened pursuant to section\n113.12\n(p)(2)\nof this Part, if not included on the cannabis product label pursuant to section\n113.12\nof this Part. (j) The dispensing\nsite\nshall include with each product package dispensed to a patient, a package safety insert. Information provided shall include but not be limited to: (1)\nthe\nmedical cannabis product; (2)\ncontraindications; (3)\nspecific dosage directions and instructions for administration based on the\nmedical cannabis product\nform, including but not limited to onset of effect and duration of action; (4)\nwarning of adverse events and/or any potential dangers stemming from the use of medical cannabis; (5)\ninstructions for reporting adverse events as\nmay\nbe determined by the\n\nOffice; (6)\na warning about driving, operation of mechanical equipment, or making important decisions while taking medical cannabis; (7)\ninformation on tolerance, dependence and withdrawal and substance abuse, how to recognize what\nmay\nbe problematic usage of medical cannabis and obtain appropriate services or treatment; (8)\nlanguage stating that the\nmedical cannabis product\nmust be kept secure at all times, and out of sight and reach of children and pets; (9)\nlanguage stating that the\ncertified patient\nmay\nnot distribute any\nmedical cannabis product\nto anyone else; (10)\nlanguage stating that unwanted, excess, or contaminated\nmedical cannabis product\nmust be disposed of in accordance with the requirements set forth in section\n113.21\nof this Part; and\n(11)\nlanguage stating that \"This product has not been analyzed by the FDA. There is limited information on the side effects of using this product and there\nmay\nbe associated health risks.\"\n(k) The dispensing\nsite\nshall store the\nmedical cannabis product\nin a manner to ensure that there is no contamination or deterioration of the\nmedical cannabis product\nor its packaging. (l) If a\nmedical cannabis product\nis returned to the dispensing\nsite, the dispensing\nsite\nshall: (1)\ndispose of such product pursuant to section\n113.25\nof this Part; (2)\nretain the following information for at least five (5) years and make available to the\n\nOffice\nupon request: (i) the name and registry identification number of the\ncertified patient\nfor whom the product was dispensed; (ii)\nthe date of the return; (iii)\nthe product being returned; (iv)\nthe quantity and/or weight being returned; (v) the reason for the return; (vi)\nthe name of the dispensing\nsite\nemployee accepting the return; and\n(vii)\nany other information required by the\n\nOffice; (3)\nensure the returned\nmedical cannabis product\nis securely stored, separate from working inventory while awaiting disposal. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\n§\n113.13\n\nAdopted\n\nNew York\n\nState\n\nRegister February 22, 2023/Volume XLV, Issue 08, eff. 2/22/2023",
  "url_type": "regulation",
  "source_index": 8113
}